Kolchinsky and Shah Disclose 14.6% Stake in Bambusa Therapeutics

Peter Kolchinsky and Rajeev Shah disclosed beneficial ownership of 7,429,758 shares, equal to 14.6% of Bambusa Therapeutics’ common stock, in a Schedule 13D.